Summary of Significant Accounting Policies (Details) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Summary of Significant Accounting Policies
Reserves for product returns	$ 2,600,000		$ 2,300,000	$ 3,800,000
Increase in estimates of reserve	$ 800,000	$ 4,400,000
Accrued contract rebates			279,018	379,242
Revenue practical expedient, financing component	true
Deferred Revenue	$ 0		281,372	$ 70,343
Prescription Medications
Summary of Significant Accounting Policies
Reserves for sales deductions	$ 3,300,000		$ 3,000,000.0
Medical Devices
Summary of Significant Accounting Policies
Right to return and receive credit for product	90 days
Minimum | Prescription Medications
Summary of Significant Accounting Policies
Due period for invoice payments	30 days
Right to return and receive credit for product	6 months
Minimum | Medical Devices | Domestic customers
Summary of Significant Accounting Policies
Due period for invoice payments	30 days
Maximum | Prescription Medications
Summary of Significant Accounting Policies
Due period for invoice payments	75 days
Right to return and receive credit for product	1 year
Maximum | Medical Devices | International customers
Summary of Significant Accounting Policies
Due period for invoice payments	90 days